Not Yet RecruitingPhase 4ACTRN12605000065695

The effect of intrathecal pethidine on shivering in women having caesarean sections: a prospective randomised controlled trial

Sponsor

Box Hill Hospital, Eastern Health

Enrollment

40 participants

Start Date

Sep 1, 2005

Study Type

Interventional

Conditions

Shivering in women having caesarean sections under spinal anaesthetics

Eligibility

Sex: Females

Plain Language Summary

Simplified for easier understanding

This study tests whether adding pethidine (a pain medication) to the spinal anaesthetic given for caesarean section can reduce shivering, a common side effect. It is for women having urgent caesarean sections under spinal anaesthesia. Participation involves receiving the standard or modified spinal anaesthetic.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Women presenting for emergency caesarean section (E1-E3) will be randomised to one of two groups, and either receive intrathecal pethidine 10mg with bupivacaine, or intrathecal fentanyl 10mcg with bupivacaine. Our hypothesis is that women receiving pethidine will experience less shivering than those receiveing fentanyl. The intervention will last four hours only.

Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12605000065695